Literature DB >> 18357510

Specific pathogen free conditions prevent transthyretin amyloidosis in mouse models.

Seiya Inoue1, Mika Ohta, Zhenghua Li, Gang Zhao, Yutaka Takaoka, Naomi Sakashita, Kazuhisa Miyakawa, Koji Takada, Hajime Tei, Misao Suzuki, Michio Masuoka, Yoshiyuki Sakaki, Kiyoshi Takahashi, Ken-Ichi Yamamura.   

Abstract

Transthyretin (TTR) associated amyloidosis is an autosomal dominant disorder characterized by peripheral and autonomic neuropathy. Both genetic and environmental factors are thought to be involved in development of TTR associated amyloidosis. Previously, we demonstrated that amyloid deposition was observed in various tissues of transgenic mouse lines carrying a human mutant TTR (Met30) gene. To analyze the influence of environmental factors on TTR amyloidosis, these amyloidogenic transgenic mouse models were kept under conventional (CV) or specific pathogen free (SPF) conditions. Although the serum levels of Met30 for mice housed in the CV and SPF conditions were similar, amyloid deposition was observed in CV conditions, but not in SPF conditions. In addition, the extent of amyloid deposition in transgenic mice was dependent on duration kept under CV conditions. There were significant differences in proportion of amyloid deposition in several tissues between CV and SPF conditions. Maintenance of these mice at 30 degrees C did not induce amyloid deposition in SPF conditions. These results suggest that the SPF conditions can completely prevent amyloid deposition, and that environmental factors can affect the onset and progression even in a single gene disorder.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18357510     DOI: 10.1007/s11248-008-9180-9

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  39 in total

1.  Cytokine production profile of splenocytes derived from zymosan A-treated SKG mice developing arthritis.

Authors:  K Kobayashi; T Suda; K Nan-Ya; N Sakaguchi; S Sakaguchi; I Miki
Journal:  Inflamm Res       Date:  2006-08       Impact factor: 4.575

Review 2.  Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidoses.

Authors:  Steven M Johnson; R Luke Wiseman; Yoshiki Sekijima; Nora S Green; Sara L Adamski-Werner; Jeffery W Kelly
Journal:  Acc Chem Res       Date:  2005-12       Impact factor: 22.384

Review 3.  Liver transplantation and new therapeutic approaches for familial amyloidotic polyneuropathy (FAP).

Authors:  Yukio Ando
Journal:  Med Mol Morphol       Date:  2005-09       Impact factor: 2.309

Review 4.  Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts).

Authors:  G G Glenner
Journal:  N Engl J Med       Date:  1980-06-12       Impact factor: 91.245

5.  Oxidative stress is found in amyloid deposits in systemic amyloidosis.

Authors:  Y Ando; N Nyhlin; O Suhr; G Holmgren; K Uchida; M el Sahly; T Yamashita; H Terasaki; M Nakamura; M Uchino; M Ando
Journal:  Biochem Biophys Res Commun       Date:  1997-03-17       Impact factor: 3.575

6.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

7.  Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset.

Authors:  Nancy S Wexler; Judith Lorimer; Julie Porter; Fidela Gomez; Carol Moskowitz; Edith Shackell; Karen Marder; Graciela Penchaszadeh; Simone A Roberts; Javier Gayán; Denise Brocklebank; Stacey S Cherny; Lon R Cardon; Jacqueline Gray; Stephen R Dlouhy; Sandra Wiktorski; Marion E Hodes; P Michael Conneally; Jack B Penney; James Gusella; Jang-Ho Cha; Michael Irizarry; Diana Rosas; Steven Hersch; Zane Hollingsworth; Marcy MacDonald; Anne B Young; J Michael Andresen; David E Housman; Margot Mieja De Young; Ernesto Bonilla; Theresa Stillings; Americo Negrette; S Robert Snodgrass; Maria Dolores Martinez-Jaurrieta; Maria A Ramos-Arroyo; Jacqueline Bickham; Juan Sanchez Ramos; Frederick Marshall; Ira Shoulson; Gustavo J Rey; Andrew Feigin; Norman Arnheim; Amarilis Acevedo-Cruz; Leticia Acosta; Jose Alvir; Kenneth Fischbeck; Leslie M Thompson; Angela Young; Leon Dure; Christopher J O'Brien; Jane Paulsen; Adam Brickman; Denise Krch; Shelley Peery; Penelope Hogarth; Donald S Higgins; Bernhard Landwehrmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

8.  Tissue-specific and developmental expression of human transthyretin gene in transgenic mice.

Authors:  K Yamamura; S Wakasugi; S Maeda; T Inomoto; T Iwanaga; M Uehira; K Araki; J Miyazaki; K Shimada
Journal:  Dev Genet       Date:  1987

9.  Cysteine 10 is a key residue in amyloidogenesis of human transthyretin Val30Met.

Authors:  Yutaka Takaoka; Mika Ohta; Kazuhisa Miyakawa; Osamu Nakamura; Misao Suzuki; Kiyoshi Takahashi; Ken-Ichi Yamamura; Yoshiyuki Sakaki
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

10.  Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met30) gene. Pathologic similarity to human familial amyloidotic polyneuropathy, type I.

Authors:  S Yi; K Takahashi; M Naito; F Tashiro; S Wakasugi; S Maeda; K Shimada; K Yamamura; S Araki
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

View more
  4 in total

1.  Human TTRV30M localization within podocytes in a transgenic mouse model of transthyretin related amyloidosis: does the environment play a role?

Authors:  Ioannis Petrakis; Vasiliki Mavroeidi; Kostas Stylianou; George Efthymiou; Kostas Perakis; Eleftheria Vardaki; Spyridon Stratigis; Kostas Giannakakis; Kostas Kourouniotis; George Amoiridis; Andreas Plaitakis; Maria Joao Saraiva; Ken Ichi Yamamura; Eugene Daphnis
Journal:  Transgenic Res       Date:  2012-07-18       Impact factor: 2.788

Review 2.  Animal models of human amyloidoses: are transgenic mice worth the time and trouble?

Authors:  Joel N Buxbaum
Journal:  FEBS Lett       Date:  2009-07-20       Impact factor: 4.124

3.  Co-precipitation molecules hemopexin and transferrin may be key molecules for fibrillogenesis in TTR V30M amyloidogenesis.

Authors:  Mika Ohta; Aki Sugano; Naoya Hatano; Hirotaka Sato; Hirofumi Shimada; Hitoshi Niwa; Toshiyuki Sakaeda; Hajime Tei; Yoshiyuki Sakaki; Ken-Ichi Yamamura; Yutaka Takaoka
Journal:  Transgenic Res       Date:  2017-12-29       Impact factor: 2.788

4.  Plasmin activity promotes amyloid deposition in a transgenic model of human transthyretin amyloidosis.

Authors:  Ivana Slamova; Rozita Adib; Stephan Ellmerich; Michal R Golos; Janet A Gilbertson; Nicola Botcher; Diana Canetti; Graham W Taylor; Nigel Rendell; Glenys A Tennent; Guglielmo Verona; Riccardo Porcari; P Patrizia Mangione; Julian D Gillmore; Mark B Pepys; Vittorio Bellotti; Philip N Hawkins; Raya Al-Shawi; J Paul Simons
Journal:  Nat Commun       Date:  2021-12-07       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.